← All trials
NCT00557817
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2004
- Primary completion
- Aug 1, 2008
- Completion date
- Aug 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 125
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of LiegeLead sponsor
- AmgenCollaborator
- Katholieke Universiteit LeuvenCollaborator
- Free University of BrusselsCollaborator
- Katholieke Universiteit LeuvenOverall official - principal investigator
- Free University of BrusselsOverall official - principal investigator
- CHR CitadelleOverall official - principal investigator
- Chu De LiègeOverall official - principal investigator
- Chu De LiègeStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.